0I1.F Stock Analysis
0I
Uncovered
Myhealthchecked PLC is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Market cap $B
0.01
Dividend yield
—
Shares outstanding
780.09 B
MyHealthChecked Plc operates as a holding company. The firm is specialized in the development and commercialization of a range of at-home healthcare and wellness tests. The firm operates through its two subsidiaries, Concepta Diagnostics Limited and The Genome Store Limited. The firm provides various testing products, including Inbound Pre-Departure Rapid Antigen Test; inbound test for fully vaccinated travelers entering the United Kingdom, including Day 2 COVID-19 PCR travel test for fully vaccinated travelers entering the United Kingdom; inbound tests for non-vaccinated travelers entering the United Kingdom, including Day 2 COVID-19 PCR travel test, Day 2 & Day 8 COVID-19 PCR travel test package, Day 8 COVID-19 PCR travel test and Test-to-Release COVID-19 PCR test; outbound tests for travelers leaving the United Kingdom, including Fit-to-Fly COVID-19 PCR test and The Fit-to-Fly Rapid Antigen Test and recovery certificate.